Coherus BioSciences $57.5 million follow-on offering
The stock is listed on the Nasdaq Global Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Emergent BioSolutions $150 million at-the-market offering
The shares are listed on the NYSE
Mirion Technologies $52.9 million secondary offering
The shares are listed on the NYSE
Olema Pharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Integral Ad Science $165.6 million secondary offering
The stock is listed on the Nasdaq Global Market
Hayward Holdings $286 million secondary offering
The stock is listed on the New York Stock Exchange
Beyond Meat $200 million at-the-market offering
The stock offering is SEC-registered
Privia Health Group $936 million secondary offering
We advised Privia on the registered secondary offering
PGE $300 million at-the-market offering
The common stock is listed on the NYSE
IDEAYA Biosciences $201 million equity offering
The common stock is listed on the Nasdaq Global Select Market